Brain abscess with Ureaplasma parvum in a patient with granulomatosis with polyangiitis.

"Declarations Conflict of interestM. Madlener has no relevant financial or non-financial interests to disclose. M. Breuninger has no relevant financial or non-financial interests to disclose. A. Meißner has no relevant financial or non-financial interests to disclose. H. Stetefeld has no relevant financial or non-financial interests to disclose. S. Telentschak has no relevant financial or non-financial interests to disclose. T. Wille has no relevant financial or non-financial interests to disclose. T. van Eimeren has no relevant financial or non-financial interests to disclose. N. Jung has received lecture fees from Gilead, Infectopharm, MSD, Bayer and Labor Stein and travel grants from Gilead, Basilea, Correvio, Pfizer and Novartis and grants from an observational study from Infectofos. Ethical approvalThis case report was conducted following the 1964 Declaration of Helsinki and its subsequent amendments. Consent to publishThe participant has consented to the submission of the case report to the journal. AuthorshipAll named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published. Conflict of interest M. Madlener has no relevant financial or non-financial interests to disclose. M. Breuninger has no relevant financial or non-financial interests to disclose. A. Meißner has no relevant financial or non-financial interests to disclose. H. Stetefeld has no relevant financial or non-financial interests to disclose. S. Telentschak has no relevant financial or non-financial interests to disclose. T. Wille has no relevant financial or non-financial interests to disclose. T. van Eimeren has no relevant financial or non-financial interests to disclose. N. Jung has received lecture fees from Gilead, Infectopharm, MSD, Bayer and Labor Stein and travel grants from Gilead, Basilea, Correvio, Pfizer and Novartis and grants from an observational study from Infectofos."

"Funding Open Access funding enabled and organized by Projekt DEAL. No funding or sponsorship was received for this study or publication of this article."